Allurion Technologies Inc (ALUR)
1.88
+0.02
(+1.08%)
USD |
NYSE |
May 17, 16:00
1.90
+0.02
(+1.06%)
Pre-Market: 20:00
Allurion Technologies Research and Development Expense (Annual): 27.69M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.69M |
| December 31, 2022 | 16.97M |
| Date | Value |
|---|---|
| December 31, 2021 | 5.729M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
5.729M
Minimum
2021
27.69M
Maximum
2023
16.80M
Average
16.97M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Outset Medical Inc | 57.31M |
| Paragon 28 Inc | 30.08M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |
| Asensus Surgical Inc | 37.02M |